awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26796415-7DD0766C-69FC-4904-9E66-EF49019C7287
Q26796415-7DD0766C-69FC-4904-9E66-EF49019C7287
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796415-7DD0766C-69FC-4904-9E66-EF49019C7287
Pharmacologic therapy for inflammatory bowel disease refractory to steroids
P2860
Q26796415-7DD0766C-69FC-4904-9E66-EF49019C7287
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796415-7DD0766C-69FC-4904-9E66-EF49019C7287
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
28e8c4ebf9275b2c6e2236879a0e6b134e23aa75
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.